Compound Lincomycin and Spectinomycin Injectiion 10%+5%

Name: Compound Lincomycin and Spectinomycin Injectiion 10%+5%
Brand: Shandong Ginye Biotech Co., Ltd.
SKU: 2017365735

Shandong, ChinaShandong Ginye Biotech Co., Ltd.

US$2.10

5,000 vial

Sample price:US$2.30/vial.Request sample

Product profile

Customization

Available

Varieties

Infectious Disease Prevention Medicine

Component

Chemical Synthetic Drugs

Model NO.

Compound

Type

The First Class

Pharmacodynamic Influential Factors

Animal Species

Storage Method

Light Proof

Veterinary Reg. No.

Shouyaozhunzihao

Transport Package

Carton

Specification

10%+5%

Trademark

GINYE

Origin

China

HS Code

300490

Production Capacity

50000

Company profile

Shandong Ginye Biotech Co., Ltd.

Shandong, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2018-12-10Nearest Port: QINGDAOAverage Response Time: ≤3.74hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DDP

AI-Powered supplier vetting

SummaryShandong Ginye Biotech Co., Ltd. is a China-based private trading company and manufacturer focused on animal pharmaceuticals, feed additives, pet medicines, and related products. It reports ISO 9001 and GMP certification, two GMP factories, ten production lines in one description, six operating production lines in another, more than one hundred products, and dedicated R&D and quality-control personnel. The supplier began exporting in 2018, with exports representing 51%–70% of total sales, and reports cooperation with several animal-health research institutions. Evidence confirms production, certification, export activity, and research cooperation, but does not establish after-sales processes, customization services, audited financial strength, or a broad customer track record.

Supplier typeThe supplier is explicitly identified as both a trading company and manufacturer/factory. Its stated business includes research, production, and trading of animal pharmaceuticals, feed additives, and pet products, indicating an integrated supplier model rather than a pure intermediary.

CertificationsThe supplier reports ISO 9001 and GMP certification and states that it operates its quality management system according to GMP standards. These statements provide explicit evidence of formal quality-system and GMP compliance claims.

R&D capabilityThe supplier describes research and development as part of its core business and reports cooperation with Shandong Agricultural Academy, China Veterinary Herb Medicine Industry Research Institute, Shandong Herb Medicine University, and Shandong Agricultural University. It also states that it researches and commercializes recent research results, supporting an established innovation orientation.

Production capacityThe supplier reports two modern GMP factories, ten production lines in one description, six operating production lines in another, and more than one hundred products across multiple dosage forms. It also reports 11–20 quality-control staff and annual output data, providing explicit evidence of substantial manufacturing capacity, although the differing line counts should be clarified.

Client casesThe records show transaction or buyer associations involving Vietnam, Pakistan, and Bangladesh, including SHAH POULTRY INTERNATIONAL and CHEMBIO TECH LTD, and identify products such as CEFGIN-100 and a vitamin premix. These records demonstrate some cross-border commercial activity, but the limited number of transactions does not establish a broad or well-documented customer portfolio.